Clinical Trial Update: PITT PCI Xience Registry

View source ↗

Summary

Clinical update on the PITT PCI Xience Registry, a completed registry study involving patients with coronary artery disease treated with XIENCE stents.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Xience (everolimus-eluting stent with permanent polymer)

Snippet

Sponsor: University of Pittsburgh | Conditions: Coronary Artery Disease | Status: COMPLETED